The latest price of larotrectinib in 2024

Larotrectinib is a targeted anti-cancer drug that belongs to a class of tyrosine kinase inhibitors. It is an innovative treatment designed to treat certain types of cancer, especially tumors carrying NTRK gene fusions.

Larotrectinib has been launched in China and has not yet been included in medical insurance. Since it has not been launched in China for a long time, it may be difficult to purchase it inhospitals. For specific conditions, it is recommended to consult the local hospital pharmacy. In foreign markets, larotinib has two options: original drug and generic drug. Original drugs include the German version, the American version, the European version and the Hong Kong versionoriginal drugs, with prices ranging from RMB 10,000 to RMB 20,000. In comparison,generic drugs are much cheaper. There are Lao and Bangladeshi versions of generic drugs, and the price is around two to three thousand. It is worth noting that the ingredients of original drugs and generic drugs are basically the same.

NTRKgenes are a group of genes encoding nerve growth factor receptors (Neurotrophic Tyrosine Kinase Receptors), which are involved in nerve cell growth and differentiation under normal circumstances. However, when the NTRK gene fuses abnormally, an NTRK fusion gene will be formed. This mutation may lead to abnormal cell growth and the occurrence of cancer.

Larotrectinib inhibits the activity ofNTRK fusion gene and blocks abnormal signaling pathways, thereby inhibiting the growth and division of tumor cells. This allows larotrectinib to show significant efficacy in the treatment of a variety of cancers that are positive for NTRK fusions.

Compared with traditional chemotherapy drugs, larotrectinib has more precise targeting and can kill cancer cells more effectively while causing relatively little damage to normal cells. The drug's unique properties make it an innovative cancer treatment and offer new hope to some cancer patients with NTRK fusion genes.